Development of a prognostic model to predict 90-day mortality in hospitalised cancer patients (PROMISE tool): a prospective observational study.

Autor: Mirallas O; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Martin-Cullell B; Medical Oncology Department, Hospital de la Santa Creu I Sant Pau, 08041, Barcelona, Spain., Navarro V; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Vega KS; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Recuero-Borau J; Medical Oncology Department, Hospital del Mar, 08003, Barcelona, Spain., Gómez-Puerto D; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., López-Valbuena D; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Salva de Torres C; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Andurell L; Nutritional Support Unit, Vall d'Hebron Hospital Campus, 08035, Barcelona, Spain., Pedrola A; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Berché R; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Palmas F; Nutritional Support Unit, Vall d'Hebron Hospital Campus, 08035, Barcelona, Spain., Ucha JM; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Villacampa G; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Rezqallah A; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Sanz-Beltran J; Medical Oncology Department, Hospital de la Santa Creu I Sant Pau, 08041, Barcelona, Spain., Bach R; Medical Oncology Department, Hospital del Mar, 08003, Barcelona, Spain., Bueno S; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Viaplana C; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Molina G; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Hernando-Calvo A; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Aguilar-Company J; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Roca M; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Muñoz-Couselo E; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Martínez-Martí A; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Alonso A; Nursing Department, Vall d'Hebron Hospital Campus, 08035, Barcelona, Spain., Eremiev S; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Macarulla T; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Oaknin A; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Saura C; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Élez E; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Felip E; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Peñuelas Á; Nursing Department, Vall d'Hebron Hospital Campus, 08035, Barcelona, Spain., Burgos R; Nutritional Support Unit, Vall d'Hebron Hospital Campus, 08035, Barcelona, Spain., Pardo PG; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Garralda E; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Tabernero J; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Serradell S; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Servitja S; Medical Oncology Department, Hospital del Mar, 08003, Barcelona, Spain., Paez D; Medical Oncology Department, Hospital de la Santa Creu I Sant Pau, 08041, Barcelona, Spain., Dienstmann R; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Carles J; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain.

Publikováno v: The Lancet regional health. Europe [Lancet Reg Health Eur] 2024 Oct 09; Vol. 46, pp. 101063. Date of Electronic Publication: 2024 Oct 09 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

1742P Factors influencing awareness of patient associations in sarcoma: A multicentric cross-sectional study

Autor: Mascaró Baselga, P., Villacampa, G., Navarro Garces, V., Sebio Garcia, A., Alvarez, R.M., Sala Gonzalez, M.A., Marquina Ospina, G., Martinez Trufero, J., Cano, J.M., Redondo, A., Molina Diaz, A., Vega Cano, K.S., Salva de Torres, C., Yaringaño Cerna, J.G., Martínez-Albaladejo, P., de Torner Vidal, A., Cicala, C.M., Tabernero, J., Valverde Morales, C.M., Serrano, C.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S1041-S1042

Somatic Mutations Enriched in Cis-Regulatory Elements Affect Genes Involved in Embryonic Development and Immune System Response in Neuroblastoma

Autor: Lasorsa VA, Montella A, Cantalupo S, Tirelli M, de Torres C, Aveic S, Tonini GP, Iolascon A, Capasso M

Publikováno v: CANCER RESEARCH
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

Noncoding cis-regulatory variants have gained interest as cancer drivers, yet progress in understanding their significance is hindered by the numerous challenges and limitations of variant prioritization. To overcome these limitations, we focused on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::d4c439eac0d21f590c11ff3c651a6e28
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20742

WT1-Mutant Wilms Tumor Progression Is Associated With Diverting Clonal Mutations of CTNNB1

Autor: Duhme C, Busch M, Heine E, de Torres C, Mora J, Royer-Pokora B

Publikováno v: JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

WT1-mutant Wilms tumors exhibit a high rate of concomitant CTNNB1 mutations, associated with activated Wnt signaling. Here, we show by laser and manual microdissection of different histologic cell types from 6 WT1-mutant tumor samples that 1 patient'

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::54aa68977652003430f101529eaf5e84
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17118